跳到正文
原文
Nature 健康护理主题·· 7 天前AI 评分35

机器学习模型预测埃塞俄比亚中裂谷地区疑似肺结核患者的肺结核

Machine learning model development for predicting pulmonary tuberculosis in symptomatic patients from Ethiopia’s Mid-Rift Valley

AI 导读

研究开发并测试了八种监督机器学习模型,以预测埃塞俄比亚中裂谷地区疑似肺结核患者的肺结核状态。随机森林模型表现最佳,AUC为0.94(95% CI 0.90–0.97),准确率为0.88(95% CI 0.84–0.91),灵敏度为0.83(95% CI 0.69–0.92),特异度为0.89(95% CI 0.84–0.92)。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Tuberculosis continues to pose a serious health threat to high-burden countries, including Ethiopia. Complex interactions among multiple risk factors challenge disease control. Conventional epidemiological methods often fail to capture the complex interactions among risk factors; as a result, targeted interventions to control and prevent the disease are often less effective. The present study attempted to develop and test eight supervised machine learning models to address the methodological gap using comprehensive data collected from tuberculosis-suspected individuals attending public hospitals in the Mid-Rift Valley area of Ethiopia. A cross-sectional study using consecutive sampling was carried out between December 30, 2023, and January 2025 at five hospitals in the Mid-Rift Valley, Ethiopia. The required sociodemographic, clinical, and behavioral data, along with sputum samples, were collected from study subjects with signs and symptoms suggestive of TB using a structured questionnaire. Sputum samples collected from 2025 individuals suspected of having TB at OPDs were tested using the GeneXpert MTB/RIF assay for TB diagnosis. Data were split into training (70%), validation (15%), and test (15%) sets before applying the models. Eight supervised ML models were trained and tuned. Model performance was assessed using metrics: Area Under the Curve (AUC), accuracy, sensitivity, and specificity. 95% confidence intervals were computed using bootstrap resampling (1000 replicates; percentile interval method) for AUC and F1-score, and the Wilson score interval for binomial proportions. We interpreted the best model using SHAP (SHapley Additive exPlanations) and permutation importance. The data were analyzed using Jupyter Notebook, Python Version 3.12.4. Tuberculosis was diagnosed in 280 (13.8%) of the 2025 participants in the study. The Random Forest model performed best at predicting tuberculosis positivity. The final test set showed an AUC of 0.94 (95% CI 0.90–0.97), with an accuracy of 0.88 (95% CI 0.84–0.91), sensitivity of 0.83 (95% CI 0.69–0.92), and specificity of 0.89 (95% CI 0.84–0.92). HIV status, age, Body Mass Index (BMI), Bacillus Calmette-Guérin (BCG) vaccination history, night sweats, and weight loss were identified as strong predictors of tuberculosis disease in the Random Forest model. The Random Forest algorithm showed the best performance in predicting tuberculosis status, based on actual patient data in a high-burden setting. It also showed good promise as a clinical decision-support tool. However, further external validation in independent populations is required before routine clinical implementation.

Abbreviations

AIDS:

Acquired immunodeficiency syndrome

ANN:

Artificial neural networks

AUC:

Area under curve

BCG:

Bacillus Calmette–Guérin

BMI:

Body mass index

CART:

Classification and regression tree

CXR:

Chest X-ray

DNA:

Deoxyribonucleic acid

EDA:

Exploratory data analysis

FN:

False negative

FP:

False positive

HIV:

Human immunodeficiency virus

KNN:

K-nearest neighbors

LR:

Logistic regression

MDR-TB:

Multidrug-resistant TB

ML:

Machine learning

NAAT:

Nucleic acid amplification test

NB:

Naïve Bayes

NPV:

Negative predictive value

OPD:

Outpatient department

PPV:

Positive predictive value

PTB:

Pulmonary tuberculosis

RF:

Random forest

ROC:

Receiver operating characteristic

SHAP:

SHAPley Additive exPlanations

SMD:

Standardized mean difference

SVM:

Support vector machine

TB:

Tuberculosis

TN:

True negative

TP:

True positive

WHO:

World Health Organization

XDR-TB::

Extensively drug-resistant TB

XGBoost:

Extreme gradient boosting

Acknowledgements

We extend our sincere gratitude to the Department of Microbial, Cellular, and Genetics at Addis Ababa University for providing the institutional support and academic environment essential for this research. We are also deeply grateful to the Oromia Regional Health Bureau for their invaluable collaboration, including granting the administrative clearance required to conduct this study in the region’s health facilities, as well as their financial support for the data collection. Our heartfelt thanks go to the dedicated team of laboratory technologists across the five participating hospitals for their diligence and professionalism in collecting the data and samples. Our sincere gratitude goes to Dr. Mekdimu Mezemir Damte for his invaluable guidance and multifaceted support. Finally, and most importantly, we would like to express our sincere appreciation to all the study participants who voluntarily gave their time and provided samples.

Funding

This research received no external funding.

Author information

Authors and Affiliations

  1. Department of Microbial Sciences and Genetics, College of Natural and Computational Sciences, Addis Ababa University, Addis Ababa, Ethiopia

    Dereje Bekele, Helen Nigussie, Mujib Abdulkadir & Gadissa Gutema

  2. Communicable and Non-Communicable Diseases Prevention and Control Directorate, Oromia Region Health Bureau, Addis Ababa, Ethiopia

    Dereje Bekele

  3. Center for Population and Gender Studies, School of Development Studies, Addis Ababa University, Addis Ababa, Ethiopia

    Tariku Dejene

  4. Ethiopian Public Health Institute, Addis Ababa, Ethiopia

    Getu Diriba, Gadissa Gutema & Dawit Wolday

  5. Department of Biotechnology, School of Bioscience and Technology, Wollo University, Dessie, Ethiopia

    Desye Melese Sisay

  6. Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, P.O. Box 1176, Addis Ababa, Ethiopia

    Desye Melese Sisay

  7. Health Promotion and Disease Prevention Directorate, Addis Ababa City Administration Health Bureau, Addis Ababa, Ethiopia

    Melat Mezemir

  8. Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada

    Dawit Wolday

  9. Department of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands

    Tobias F. Rinke de Wit

  10. Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Hong Kong

    Gilman Siu

  11. Department of Applied Biology, School of Applied Natural Science, Adama Science and Technology University, Adama, Ethiopia

    Ketema Tafess

  12. Institute of Pharmaceutical Science, Adama Science and Technology University, Adama, Ethiopia

    Ketema Tafess

Authors

  1. Dereje Bekele
  2. Helen Nigussie
  3. Mujib Abdulkadir
  4. Tariku Dejene
  5. Getu Diriba
  6. Gadissa Gutema
  7. Desye Melese Sisay
  8. Melat Mezemir
  9. Dawit Wolday
  10. Tobias F. Rinke de Wit
  11. Gilman Siu
  12. Ketema Tafess

Corresponding author

Correspondence to Dereje Bekele.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

The College of Natural & Computational Sciences Institutional Review Board (CNCS-IRB) at Addis Ababa University approved the study. A permission letter was obtained from the Oromia Regional Health Bureau. We obtained informed consent from both participants and the legal guardian for those under 15 years of age. To ensure strict confidentiality, the study used only code numbers throughout. These procedures followed the Declaration of Helsinki.

Consent for publication

Not applicable.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bekele, D., Nigussie, H., Abdulkadir, M. et al. Machine learning model development for predicting pulmonary tuberculosis in symptomatic patients from Ethiopia’s Mid-Rift Valley. Sci Rep (2026). https://doi.org/10.1038/s41598-026-78644-6

Download citation

  • Received: 13 December 2025

  • Accepted: 27 October 2026

  • Published: 13 November 2026

  • DOI: https://doi.org/10.1038/s41598-026-78644-6

Keywords

来源:Nature 健康护理主题 · nature.com